Dose-response and efficacy of 904 nm photobiomodulation on diabetic foot ulcers healing: a randomized controlled trial

Vinicius Saura Cardoso,Pedro Renan de Souza Lima da Silveira,Cristiana Maria dos Santos,Mariana Bezerra Miranda,Ana Carolina Silva Barros,Lorena Coelho Veloso,Alessandra Tanuri Magalhães,Rebeca Barbosa da Rocha,Fuad Ahmad Hazime
DOI: https://doi.org/10.1007/s10103-024-04090-3
2024-05-29
Lasers in Medical Science
Abstract:Purpose: This study aimed to examine the impact of a 904 nm photobiomodulation (PBM) on diabetic ulcers using varying dosages. Methods: The study was a randomized, double-blind, placebo-controlled clinical trial that compared treatments using PBM (GaAs 904 nm 30w) with three different energy densities (4 J/cm 2 ; 8 J/cm 2 ; 10 J/cm 2 ) in the healing process of non-infected diabetic foot ulcers. Eighty volunteers (48.75% female; 58.5 ± 11.1 years) were randomized into three intervention groups treated with PBM and one control group (PBM placebo). Volunteers performed up 20 interventions with PBM, either placebo or actual, in conjunction with conventional therapy, which involved dressing the wound with Helianthus annuus vegetable oil. The primary variable was the ulcer size reduction rate. Results: GaAs 904 nm PBM yielded a clinically and significant ulcer size rate reduction of diabetic foot ulcers, independently of energy density range ( p < 0.05). However, 10 J/cm2 had 60% of completely healed ulcers and the highest proportion of patients reaching 50% of ulcer reduction rate after 5 weeks of treatment. In addition, only 10 J/cm2 showed a significant difference between control group after a 10-week follow-up ( p < 0.05). Conclusion: GaAs 904 nm PBM was effective in treating diabetic foot ulcers in this study and a dosage of 10 J/cm2, after a 10-week follow-up, proved to be the most effective compared to the other groups. Clinical Trial Registration number: NCT04246814.
engineering, biomedical,surgery
What problem does this paper attempt to address?